196 research outputs found

    Oumar Dia, Renée Colin-Noguès, Yâkâré, Pour une communauté migrante ouverte et fraternelle

    Get PDF
    Ouvrir les pages de Yâkâré, c’est revenir sur l’histoire d’un texte d’abord publié en 1982 aux éditions Maspéro sous le titre Autobiographie d’Oumar. Entre 1982 et 2012, tout un chemin parcouru qui autorise cette nouvelle lecture, mise en perspective à la lumière contemporaine puisque l’ouvrage est complété d’un épilogue : “Vingt ans après : le monde a changé, en France, sur le Fleuve et ailleurs, mais je persiste et je signe.” La voix d’Oumar a donc porté jusqu’à nous, nous arrive à nouveau ..

    Technologie d'optique intégrée polymère au laboratoire FOTON

    No full text
    National audienceCet article résume le panorama de l'état de l'art des technologies d'optique intégrée polymère maitrisées au laboratoire Foton (Systèmes Photoniques) et qui sont axées sur des circuits optiques actifs et passifs. Les objectifs sont orientés vers un fort confinement du mode de propagation, la génération d'effets non linéaires, l'hybridation avec d'autres matériaux et la réduction des pertes (couplage et propagation)

    Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma.

    Get PDF
    RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are.BACKGROUND: Pilocytic astrocytomas occur predominantly in childhood. In contrast to the posterior fossa location, hypothalamo-chiasmatic pilocytic astrocytomas display a worse prognosis often leading to multiple surgical procedures and/or several lines of chemotherapy and radiotherapy to achieve long-term control. Hypothalamo-chiasmatic pilocytic astrocytomas and cerebellar pilocytic astrocytomas have a distinctive gene signature and several differential expressed genes (ICAM1, CRK, CD36, and IQGAP1) are targets for available drugs: fluvastatin and/or celecoxib. RESULTS: Quantification by RT-Q-PCR of the expression of these genes was performed in a series of 51 pilocytic astrocytomas and 10 glioblastomas: they were all significantly overexpressed in hypothalamo-chiasmatic pilocytic astrocytomas relative to cerebellar pilocytic astrocytomas, and CRK and ICAM1 were significantly overexpressed in pilocytic astrocytomas versus glioblastomas.We used two commercially available glioblastoma cell lines and three pilocytic astrocytoma explant cultures to investigate the effect of celecoxib/fluvastatin alone or in combination. Glioblastoma cell lines were sensitive to both drugs and a combination of 100 μM celecoxib and 240 μM fluvastatin was the most synergistic. This synergistic combination was used on the explant cultures and led to massive cell death of pilocytic astrocytoma cells.As a proof of concept, a patient with a refractory multifocal pilocytic astrocytoma was successfully treated with the fluvastatin/celecoxib combination used for 18 months. It was well tolerated and led to a partial tumor response. CONCLUSION: This study reports evidence for new targets and synergistic effect of celecoxib/fluvastatin combination in pilocytic astrocytoma. Because it is non-toxic, this new strategy offers hope for the treatment of patients with refractory pilocytic astrocytoma

    Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.

    Full text link
    peer reviewedLate relapse (LR) after allogeneic hematopoietic stem cell transplantation (AHSCT) for acute leukemia is a rare event (nearly 4.5%) and raises the questions of prognosis and outcome after salvage therapy. We performed a retrospective multicentric study between January 1, 2010, and December 31, 2016, using data from the French national retrospective register ProMISe provided by the SFGM-TC (French Society for Bone Marrow Transplantation and Cellular Therapy). We included patients presenting with LR, defined as a relapse occurring at least 2 years after AHSCT. We used the Cox model to identify prognosis factors associated with LR. During the study period, a total of 7582 AHSCTs were performed in 29 centers, and 33.8% of patients relapsed. Among them, 319 (12.4%) were considered to have LR, representing an incidence of 4.2% for the entire cohort. The full dataset was available for 290 patients, including 250 (86.2%) with acute myeloid leukemia and 40 (13.8%) with acute lymphoid leukemia. The median interval from AHSCT to LR was 38.2 months (interquartile range [IQR], 29.2 to 49.7 months), and 27.2% of the patients had extramedullary involvement at LR (17.2% exclusively and 10% associated with medullary involvement). One-third of the patients had persistent full donor chimerism at LR. Median overall survival (OS) after LR was 19.9 months (IQR, 5.6 to 46.4 months). The most common salvage therapy was induction regimen (55.5%), with complete remission (CR) obtained in 50.7% of cases. Ninety-four patients (38.5%) underwent a second AHSCT, with a median OS of 20.4 months (IQR, 7.1 to 49.1 months). Nonrelapse mortality after second AHSCT was 18.2%. The Cox model identified the following factors as associated with delay of LR: disease status not in first CR at first HSCT (odds ratio [OR], 1.31; 95% confidence interval [CI], 1.04 to 1.64; P = .02) and the use of post-transplantation cyclophosphamide (OR, 2.23; 95% CI, 1.21 to 4.14; P = .01). Chronic GVHD appeared to be a protective factor (OR, .64; 95% CI, .42 to .96; P = .04). The prognosis of LR is better than in early relapse, with a median OS after LR of 19.9 months. Salvage therapy associated with a second AHSCT improves outcome and is feasible, without creating excess toxicity

    À propos de Critique de la raison nègre, par Achille Mbembe

    No full text

    Chretien Jean-Pierre, 2010, L’Invention de l’Afrique des Grands Lacs. Une histoire du XXe siècle

    No full text
    Dans cet ouvrage, Jean-Pierre Chrétien revient sur des décennies de recherches consacrées – par lui et de nombreux autres – à cette Afrique que l’Occident a jadis baptisée « des Grands Lacs », et dont il est un éminent spécialiste. Si toutes les contributions, à l’exception d’une, ont fait l’objet de publications antérieures dans diverses revues et ouvrages, il n’empêche que la réflexion, tout comme la plume, reste franche, alerte et toujours d’actualité. De fait, la sélection d’articles pro..
    • …
    corecore